Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Insights, Forecast to 2028

Table of Contents

1 Study Coverage
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Introduction
1.2 Market by Type
1.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Glycerin
1.2.3 Propylene Glycol
1.2.4 Sorbitol
1.2.5 Mannitol
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Industrial Application
1.3.3 Non-industrial Application
1.4 Study Objectives
1.5 Years Considered
2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (2017-2028)
2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region: 2017 VS 2021 VS 2028
2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region
2.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historic Production by Region (2017-2022)
2.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume & Value Estimates and Forecasts
3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Estimates and Forecasts 2017-2028
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Estimates and Forecasts 2017-2028
3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region
3.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022)
3.4.2 Global Sales Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Region (2023-2028)
3.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region
3.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022)
3.5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Manufacturers
4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers
4.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2017-2022)
4.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients in 2021
4.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers
4.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2017-2022)
4.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2021
4.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type
5.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Sales by Type (2017-2022)
5.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Sales by Type (2023-2028)
5.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type
5.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Revenue by Type (2017-2022)
5.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Revenue by Type (2023-2028)
5.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2017-2028)
5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type
5.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022)
5.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application
6.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Sales by Application (2017-2022)
6.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Sales by Application (2023-2028)
6.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application
6.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Revenue by Application (2017-2022)
6.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecasted Revenue by Application (2023-2028)
6.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2017-2028)
6.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application
6.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022)
6.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2023-2028)
7 North America
7.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
7.1.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
7.1.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
7.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
7.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
7.2.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
7.3 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
7.3.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
7.3.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
8.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
8.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
8.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
8.2.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
8.2.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
8.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
8.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
8.3.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
9.1.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
9.1.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
9.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
9.2.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
9.2.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
9.3 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region
9.3.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2028)
9.3.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
10.1.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
10.1.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
10.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
10.2.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
10.2.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
10.3 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
10.3.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
10.3.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type
11.1.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
11.1.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
11.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application
11.2.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
11.2.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
11.3 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
11.3.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2028)
11.3.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 ABITEC Corporation
12.1.1 ABITEC Corporation Corporation Information
12.1.2 ABITEC Corporation Overview
12.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 ABITEC Corporation Recent Developments
12.2 AkzoNobel
12.2.1 AkzoNobel Corporation Information
12.2.2 AkzoNobel Overview
12.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 AkzoNobel Recent Developments
12.3 Archer Daniels Midland (ADM)
12.3.1 Archer Daniels Midland (ADM) Corporation Information
12.3.2 Archer Daniels Midland (ADM) Overview
12.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Archer Daniels Midland (ADM) Recent Developments
12.4 BASF
12.4.1 BASF Corporation Information
12.4.2 BASF Overview
12.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 BASF Recent Developments
12.5 DowDuPont
12.5.1 DowDuPont Corporation Information
12.5.2 DowDuPont Overview
12.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 DowDuPont Recent Developments
12.6 Evonik
12.6.1 Evonik Corporation Information
12.6.2 Evonik Overview
12.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Evonik Recent Developments
12.7 J.M. Huber Corporation
12.7.1 J.M. Huber Corporation Corporation Information
12.7.2 J.M. Huber Corporation Overview
12.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 J.M. Huber Corporation Recent Developments
12.8 Cargill
12.8.1 Cargill Corporation Information
12.8.2 Cargill Overview
12.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Cargill Recent Developments
12.9 Eastman Chemical Company
12.9.1 Eastman Chemical Company Corporation Information
12.9.2 Eastman Chemical Company Overview
12.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Eastman Chemical Company Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Chain Analysis
13.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Mode & Process
13.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales and Marketing
13.4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Channels
13.4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors
13.5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Trends
14.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
14.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
14.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
15 Key Finding in The Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Glycerin
Table 3. Major Manufacturers of Propylene Glycol
Table 4. Major Manufacturers of Sorbitol
Table 5. Major Manufacturers of Mannitol
Table 6. Major Manufacturers of Others
Table 7. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 9. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region (2017-2022) & (K Units)
Table 10. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Region (2017-2022)
Table 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Region (2023-2028) & (K Units)
Table 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Region (2023-2028)
Table 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2022)
Table 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2023-2028)
Table 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (US$ Million)
Table 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2022)
Table 20. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (US$ Million)
Table 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2023-2028)
Table 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 23. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Capacity Market Share by Manufacturers (2017-2022)
Table 24. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2017-2022) & (K Units)
Table 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturers (2017-2022)
Table 26. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2017-2022)
Table 28. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Manufacturers 2017-2022 (USD/Unit)
Table 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Forms (OSDF) and Pharma Excipients as of 2021)
Table 31. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base Distribution and Headquarters
Table 32. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Offered
Table 33. Date of Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 37. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2017-2022)
Table 38. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2023-2028)
Table 39. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 40. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 41. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2017-2022)
Table 42. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2023-2028)
Table 43. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2023-2028) & (USD/Unit)
Table 45. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 46. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 47. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2017-2022)
Table 48. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2023-2028)
Table 49. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 50. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 51. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2017-2022)
Table 52. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2023-2028)
Table 53. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022) & (USD/Unit)
Table 54. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2023-2028) & (USD/Unit)
Table 55. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 56. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 57. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 60. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 61. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 64. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 65. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 68. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 69. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 70. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 71. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 72. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 73. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 74. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 75. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 76. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 77. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 78. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 79. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 80. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 81. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 82. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 83. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 84. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 85. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 86. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 87. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 88. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 89. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (US$ Million)
Table 90. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (US$ Million)
Table 91. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 92. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 93. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 94. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 95. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 96. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 97. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 98. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 99. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 100. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 101. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 102. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 104. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 105. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 108. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 109. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (US$ Million)
Table 111. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 112. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 113. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (US$ Million)
Table 115. ABITEC Corporation Corporation Information
Table 116. ABITEC Corporation Description and Major Businesses
Table 117. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. ABITEC Corporation Recent Development
Table 120. AkzoNobel Corporation Information
Table 121. AkzoNobel Description and Major Businesses
Table 122. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. AkzoNobel Recent Development
Table 125. Archer Daniels Midland (ADM) Corporation Information
Table 126. Archer Daniels Midland (ADM) Description and Major Businesses
Table 127. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Archer Daniels Midland (ADM) Recent Development
Table 130. BASF Corporation Information
Table 131. BASF Description and Major Business